Overview
Meditest provides medical diagnostics, including molecular genetic testing for SARS-CoV-2 using Real-time PCR and CE-IVD tests. Its services also include pathological diagnostics, cervical cancer screening, HPV tests, research and development, and psychotherapy.
Financials
Revenue history
Filing timeliness
Financial statements were filed on time, on average 54 days early.
- 202524/06/2026
- 202417/04/2025
- 202314/06/2024
- 202209/06/2023
- 202114/06/2022
- 202023/06/2021
Data and insights are generated automatically from financial statements – they may contain errors and are neither a credit assessment nor business advice.
Industry
Public procurement
Meditest is the contractor in 28 public sector contracts, worth USD 1.66k in total. All of them were signed with the same public buyer.
| Signed on | Subject | Amount | Public buyer | |
|---|---|---|---|---|
| Oct 13, 2026 | wykonanie badania cytologicznego wraz z genotypowaniem HPV | $59.43 | Samodzielny Publiczny Wojewódzki Szpital Zespolony w Szczecinie | |
| Oct 13, 2026 | wykonanie badania cytologicznego wraz z genotypowaniem HPV | $59.43 | Samodzielny Publiczny Wojewódzki Szpital Zespolony w Szczecinie | |
| Oct 13, 2026 | wykonanie badania cytologicznego wraz z genotypowaniem HPV | $59.43 | Samodzielny Publiczny Wojewódzki Szpital Zespolony w Szczecinie |
Authorized Representatives
Manner of representation
If a one-person management board is appointed, the President of the Management Board is authorised to make declarations of will on behalf of the company and represent it (independent representation). If a multi-member management board is appointed, joint action by two members of the management board or by one member of the management board acting jointly with a commercial proxy is required to make declarations of will and represent the company (joint representation), except that each member of the management board is entitled to act independently when making declarations of will on behalf of the company up to PLN 20,000 (twenty thousand zloty).
Ownership
| Owner | Shares | Share value | Stake |
|---|---|---|---|
Magdalena Zofia Podolskaage 59 | 25 | $675.31 | 50% |
Jacek Marek Podolskiage 61 | 25 | $675.31 | 50% |
Jacek Marek Podolski and Magdalena Zofia Podolska hold a combined 100% – the ownership structure indicates family control.
Beneficial owners
| Person | Rights |
|---|---|
Debt
No entries in the National Debtors Register (KRZ).
Public aid
No public aid cases recorded in the last 10 years.
Competitors
| Name | Revenue | Website | ||
|---|---|---|---|---|
| Telediagnosissp. z o.o. | $19,096,010.10 | telediagnosis.pl | ||
| Medgen Kamila Czerska I Wspólnicysp. k. | $12,536,540.98 | medgen.pl | ||
| Sonomedsp. z o.o. | $7,785,770.92 | sonomedszczecin.pl | ||
| Medika Usługi Medycznesp. z o.o. | $4,636,626.73 | medika.pl | ||
| Prenatal - Medsp. z o.o. | $945,942.32 | prenatal-med.pl | ||
| One Day Medsp. z o.o. | $811,727.30 | onkolog.szczecin.pl | ||
| WN Medicasp. z o.o. | $744,002.87 | wnmedica.pl | ||
| SCAN Medicasp. z o.o. | $674,542.39 | scanmedica.pl | ||
| Zdunomedsp. z o.o. | $493,048.57 | zdunomed.pl | ||
| Instytut Diagnostyki Molekularnej Diagmolsp. z o.o. | $203,495.41 | diagmol.pl |
FAQ
Last updated: 2026-06-24